Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaru Nishimi is active.

Publication


Featured researches published by Masaru Nishimi.


Heart Surgery Forum | 2009

Endoscopic Radial Artery Harvesting for Coronary Artery Bypass Grafting: The Initial Clinical Experience and Results of the First 50 Patients

Nobuhisa Ito; Tadashi Tashiro; Noritsugu Morishige; Hidehiko Iwahashi; Masaru Nishimi; Yoshio Hayashida; Kazuma Takeuchi; Noritoshi Minematsu; Go Kuwahara; Yuta Sukehiro

BACKGROUND The radial artery (RA) is a commonly used arterial conduit in coronary artery bypass grafting (CABG). Traditional open-vessel harvest often leads to postoperative wound complications and cosmetic problems. Endoscopic RA harvesting (ERAH) has been widely used to prevent these problems. The purpose of this study was to assess these problems and graft patency in the first 50 patients who underwent ERAH. METHODS Between February 2006 and October 2007, 50 patients underwent ERAH with the VasoView system (Boston Scientific). These patients were compared with 50 patients who underwent the traditional open technique. RESULTS The mean age was 62.8 years in both groups. All RAs were successfully harvested. No conversion was made from ERAH to the traditional open technique. The mean harvesting time (forearm ischemic time) was 27.4 + or - 6.5 minutes, and the mean length of the RA in the ERAH group was 18.5 cm. Neither wound complications, such as wound infection and skin necrosis, nor severe neurologic complications were recorded. The patency rate was 95.9% (95/99) in the ERAH group and 94% (94/100) in the open group. CONCLUSION ERAH can be performed safely, and the early results are satisfactory. Endoscopic vessel harvesting is therefore recommended as the technique of choice for RA harvesting.


Annals of Vascular Diseases | 2014

Direct and transapical central cannulation for acute type a aortic dissection.

Hideichi Wada; Hitoshi Matsumura; Noritoshi Minematsu; Mau Amako; Masaru Nishimi; Tadashi Tashiro

OBJECTIVE The choice of cannulation site for the treatment of acute Stanford type A aortic dissection is much debated. We believe that central cannulation is quick to perform, easy to use, and safe to manage acute type A aortic dissection. MATERIALS AND METHODS We retrospectively investigated 26 cases of acute aortic dissection performed using two different central cannulation methods between April 2011 and March 2012. Direct ascending aortic cannulation was performed using the Seldinger technique in 20 patients, and transapical ascending aortic cannulation was performed in six patients in whom puncture was difficult. RESULTS Patients were 21-86 years old (mean age, 67 years). The surgical techniques used to treat aortic dissection were hemiarch repair in 21 patients and total arch replacement in 5 patients. The mean length of surgery was 393 min. One death (3.8%) was attributed to intestinal ischemia. CONCLUSION During surgery for acute aortic dissection, central cannulation using either transapical or direct puncture can be performed quickly and safely, and satisfactory short-term outcomes can be obtained. Because acute aortic dissection can present with various conditions, there is no single perfect surgical or cannulation method; therefore, the choice of surgical procedure should be individualized for each patient.


Heart Surgery Forum | 2012

Safety and Efficacy of an Ultrashort-Acting β1-Blocker on Left Ventricular Dysfunction

Nobuhisa Ito; Tadashi Tashiro; Noritsugu Morishige; Masaru Nishimi; Yoshio Hayashida; Noritoshi Minematsu; Go Kuwahara; Yuta Sukehiro; Hiromitsu Teratani

Landiolol hydrochloride, an ultrashort-acting β1-selective blocker, is a highly regulated drug. This study evaluated the safety and efficacy of this drug for cases of coronary artery bypass grafting (CABG) with left ventricular dysfunction. Between September 2006 and August 2009, 32 patients with a left ventricular ejection fraction of <40% underwent CABG. Two groups of patients, a group administered landiolol hydrochloride and a control group not administered this drug, were compared. The administration of landiolol hydrochloride was initiated at 1 μg/kg per minute (γ) after cardiopulmonary bypass in on-pump cases and after completion of all the distal anastomoses in off-pump cases. We observed no significant differences between the groups with respect to preoperative patient background or incidences of complications, except for postoperative atrial fibrillation. The heart rate decreased significantly 30 minutes after landiolol hydrochloride administration, but no change was observed in arterial pressure. No change was observed in other parameters; the hemodynamics were stable. The occurrence of atrial fibrillation during the intensive care unit stay (during landiolol hydrochloride administration) was significantly lower in the administration group. The difference remained significant after multiple logistic regression analysis; landiolol hydrochloride was the sole inhibitory factor.


Heart Surgery Forum | 2010

Efficacy of Propafenone Hydrochloride in Preventing Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting

Nobuhisa Ito; Tadashi Tashiro; Noritsugu Morishige; Masaru Nishimi; Yoshio Hayashida; Kazuma Takeuchi; Noritoshi Minematsu; Go Kuwahara; Yuta Sukehiro

BACKGROUND Atrial fibrillation (AF) is one of the most common complications after coronary artery bypass grafting (CABG), and the incidence of postoperative AF (PAF) is estimated to range from 10% to 40%. PAF is a serious complication that is related to unstable hemodynamics, development of embolisms, patient discomfort, and increased medical costs associated with the prolongation of hospital stay. Sometimes, immediate attention is also necessary. In this study, we assessed the efficacy of treatment with the antiarrhythmic drug propafenone hydrochloride, which was administered in the early postoperative period, in preventing the development of PAF, and we attempted to identify risk factors for PAF. MATERIALS AND METHODS The subjects were 78 patients who underwent isolated off-pump CABG between July 2007 and October 2008. We conducted the study by dividing the patients into 2 groups, a group of 26 patients who received propafenone hydrochloride (P group) and a control group of 52 patients who did not receive this drug (C group). The patients in the P group were given propafenone hydrochloride (150-450 mg/day orally) for 10 days, starting on the day after surgery, and were observed for the development of AF by means of continuous 12-lead electrocardiographic monitoring. Development of AF was defined as AF that lasted <or=30 minutes or as supraventricular arrhythmia that required new treatment even though it did not persist for 30 minutes. RESULTS The background factors of the patients in the P and C groups were similar. The operation times and the numbers of distal anastomoses in the 2 groups were similar, and there were no particular differences between the 2 groups with respect to postoperative factors. The incidence of PAF was 35% in the C group and significantly lower in the P group (12%, P = .0337). Moreover, multiple logistic regression analysis showed that propafenone hydrochloride was the sole factor that prevented the development of PAF (odds ratio, 0.207; 95% confidence interval, 0.053-0.804; P = .0229). CONCLUSION Cases must be carefully considered before administering propafenone hydrochloride, but the results of this study indicate that propafenone hydrochloride may prevent the development of PAF.


Annals of Vascular Surgery | 2014

A Case of Type-2 Endoleak from a Bronchial Artery after Endovascular Aortic Repair for Kommerell Diverticulum

Mau Amako; Hideichi Wada; Hitoshi Matsumura; Yuichi Morita; Masayuki Shimizu; Masahiro Ohsumi; Yuta Sukehiro; Noritoshi Minematsu; Masaru Nishimi; Tadashi Tashiro

We describe a case of type-2 bronchial artery endoleak after endovascular aortic repair of Kommerell diverticulum (KD) involving right-sided aortic arch and aberrant left subclavian artery (LSA). A 68-year-old woman underwent an endovascular repair of KD with an aberrant LSA in our hospital. Follow-up computed tomography (CT) at 6 months after the procedure showed an endoleak. Digital subtraction angiography revealed a type-2 endoleak from a bronchial artery, but no type-1 or type-2 endoleak from the aberrant left subclavian artery. We performed coil embolization of the KD and the left subclavian artery. The endoleak disappeared in the postoperative CT.


Japanese Circulation Journal-english Edition | 2010

Off-pump coronary artery bypass vs percutaneous coronary intervention. Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI(PCI-Side).

Masaru Nishimi; Tadashi Tashiro


Circulation | 2010

Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention

Masaru Nishimi; Tadashi Tashiro


Journal of Cardiology Cases | 2010

Right ventricular rupture induced by cardiopulmonary resuscitation

Masahiro Natsuaki; Ayumu Yamasaki; Noritsugu Morishige; Masaru Nishimi; Masanori Okabe; Yusuke Yamamoto


Advances in Therapy | 2014

Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.

Masahiro Osumi; Tadashi Tashiro; Yuichi Morita; Shinji Kamiya; Noritoshi Minematsu; Masaru Nishimi; Hideichi Wada


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2013

Off-pump coronary artery bypass: techniques, pitfalls, and results

Tadashi Tashiro; Hideichi Wada; Masaru Nishimi; Noritoshi Minematsu

Collaboration


Dive into the Masaru Nishimi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge